Oracle's Twin Dilemma: A Founder's Personal Guarantee Collides With a Credit Downgrade
Published on 07/31/2026 at 14:52 | Redaktion boerse-global.de
The market is sending Oracle two conflicting messages at once. Equity investors are bidding the stock up, while bondholders are demanding their richest compensation in nearly two decades. The disconnect is no accident — it reflects a company caught between an unprecedented growth story and a balance sheet that rating agencies increasingly view with alarm.
The Rating Cut That Didn't Move the Needle
S&P Global Ratings lowered Oracle's long-term rating one notch to BBB- at the start of the month, with the short-term rating slipping from A-2 to A-3. The outlook remains stable, but the move leaves the company just one step above speculative territory. Moody's, meanwhile, maintains a negative outlook, keeping the threat of further downgrades alive.
Equity investors barely flinched. The stock gained 2.19 percent on the day of the announcement and has climbed roughly 12 percent over the past week. On the downgrade day itself, shares rose about 2.7 percent. The pattern suggests shareholders are looking past the credit news and focusing on the cloud infrastructure growth story instead.
Bond investors see it differently. The credit default swap spread for Oracle debt has widened to roughly 203 basis points — the highest level in almost 18 years. Ten-year Oracle bonds currently yield about 6.4 percent, noticeably above the 5.7 percent benchmark for BBB-rated debt. In practical terms, the credit market is already treating Oracle as riskier than its rating suggests.
Should investors sell immediately? Or is it worth buying Oracle?
The Numbers Behind the Divide
The core issue comes down to a single figure: free cash flow. Oracle finished its last fiscal year at negative $23.7 billion, as data center investments consume more capital than operations generate. S&P projects that gap could widen to as much as $42 billion in the current fiscal year. It's this growing financing hole, not the order book, that credit markets are pricing in.
The bull case rests on impressive growth metrics. Quarterly revenue climbed 21 percent to $19.2 billion, with the cloud business expanding 47 percent to $9.9 billion. Cloud infrastructure alone grew 93 percent. Remaining performance obligations reached $638 billion at quarter-end, up 363 percent year over year. For the full year, Oracle posted revenue of $67.4 billion, with adjusted earnings per share rising 27 percent to $7.63.
The bear case centers on concentration and funding. S&P estimates roughly half of that $638 billion backlog is tied to OpenAI — a single customer that remains deeply unprofitable. To defend its investment-grade rating, Oracle has turned to fresh equity. The company raised $5 billion through mandatory convertible preferred shares in February, plans another $20 billion capital raise later this year, and is expected to follow with additional double-digit billion amounts over the next three years.
A Founder's Fortune Enters the Equation
The stock's trajectory has been brutal by any measure. After hitting a record high of €280.70 in September 2025, shares have fallen nearly 60 percent. The stock trades around €113.04 after a 2.21 percent premarket gain, but remains down almost 32 percent year to date and nearly 49 percent over twelve months. The annualized 30-day volatility of 53.71 percent underscores how jittery trading has become.
What makes this moment unusual is that Oracle's near-term fate no longer hinges solely on cloud growth, backlog, or investment discipline. A courtroom now plays a role — one where an entertainment deal is being contested.
The Ellison Family Trust has provided an equity backstop of $45.7 billion for the Paramount Skydance acquisition of Warner Bros. Discovery, led by founder Larry Ellison's son David. Ellison personally guarantees $40.4 billion of that financing irrevocably. The catch: the trust holds roughly 1.16 billion Oracle shares, whose value has roughly halved since the guarantee was signed. Oracle's proxy filings show Ellison had already pledged 346 million shares as collateral for personal debt in September.
The collateral behind one of the largest personal financial commitments in corporate history is therefore Oracle stock itself — and that stock has been in decline for months.
The Legal Wrinkle
The deal was supposed to be done by now. The US Department of Justice cleared it in June, and the European Commission followed on July 22 with conditions on film distribution in Europe. Then came resistance from the states. Twelve attorneys general, led by California, filed suit this month arguing the combination harms competition in film and entertainment. A federal judge has halted the transaction pending resolution.
Oracle at a turning point? This analysis reveals what investors need to know now.
The resulting timeline should worry Oracle shareholders most. On Friday, July 24, Paramount accepted that the deal closes no earlier than June 1, 2027 — or five days after a ruling in the matter, whichever comes first. That leaves Ellison's guarantee open for nearly another year while the stock serving as collateral keeps falling.
What to Watch
The consensus analyst price target stands at €215.32, implying roughly 90 percent upside from current levels. That gap between analyst models and market sentiment says much about how far expectations have diverged.
Two signals deserve attention in the coming months: the terms of the planned $20 billion capital raise, and any rating agency response to the existing negative outlook. Both will reveal whether Oracle can fund its multibillion-dollar expansion without further endangering its investment-grade status.
The entanglement of founder wealth and corporate stock price gives the market another reason to demand a discount — and reason to watch the courtroom as closely as the balance sheet. For a company already wrestling with credit market skepticism over its AI-driven debt load, that's an added burden no financial model can fully capture.
Ad
Oracle Stock: New Analysis - 31 July
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
